Luohe Nanjiecun Pharma is participating in the 85th API China.
On October 14-16, 2020, our company will participate in the 85th API China.
Month: October 2020
Luohe Nanjiecun Pharma was invited to participate in the 84th API China.
On May 13-15, 2020, our company was invited to participate in the 84th API China .
Luohe Nanjiecun Pharma was invited to participate in the 2019 CPhI India.
On November 26-28, 2019, our company was invited to participate in 2019 CPhI India.
Luohe Nanjiecun Pharma was invited to participate in the 2019 CPhI Worldwide Europe.
On November 5-7, 2019, our company was invited to participate in 2019 CPhI Worldwide Europe.
Luohe Nanjiecun Pharma was invited to participate in the 83th API China.
October 10-12, 2019, our company was invited to participate in the 83th API China
Luohe Nanjiecun Pharma was invited to participate in the 2019 CPhI China.
June 18-20, 2019, our company was invited to participate in the 2019 CPhI China.
Luohe Nanjiecun Pharma was invited to participate in the 82th API China.
May 8-10, 2019, our company was invited to participate in the 82th API China.
What is rifabutin?
Rifabutin is an antibiotic that fights bacteria. Generic Name: rifabutin (RIF a BUE tin)Brand Name: Mycobutin Rifabutin is used to prevent mycobacterium avium complex (MAC) in people with HIV (human immunodeficiency virus) infection. Rifabutin is also used with other medicines to treat tuberculosis in people with HIV. Rifabutin may also be used for purposes not listed in this medication guide. Mycobacterium avium complex …
China Pharma Forecast 2019-2023
China has expanded to be the second largest pharmaceutical market globally with USD 137 billion in total spending in 2018, but growth has slowed from a 19% CAGR in 2008–2013 to an 8% CAGR in 2013–2018 and is expected to continue to decline to 3-6% through 2023, as the below charts show. Much of China’s growth …
What is multidrug-resistant tuberculosis and how do we control it?
The bacteria that cause tuberculosis (TB) can develop resistance to the antimicrobial drugs used to cure the disease. Multidrug-resistant TB (MDR-TB) is TB that does not respond to at least isoniazid and rifampicin, the 2 most powerful anti-TB drugs. The 2 reasons why multidrug resistance continues to emerge and spread are mismanagement of TB treatment …
What is multidrug-resistant tuberculosis and how do we control it? Read More »
